Novel candidate cancer genes identified by a large-scale cross-species comparative oncogenomics approach

Jenny Mattison, Jaap Kool, Anthony G. Uren, Jeroen De Ridder, Lodewyk Wessels, Jos Jonkers, Graham R. Bignell, Adam Butler, Alistair G. Rust, Markus Brosch, Catherine H. Wilson, Louise Van Der Weyden, David A. Largaespada, Michael R. Stratton, P. Andy Futreal, Maarten Van Lohuizen, Anton Berns, Lara S. Collier, Tim Hubbard, David J. Adams

Research output: Contribution to journalArticlepeer-review

35 Scopus citations


Comparative genomic hybridization (CGH) can reveal important disease genes but the large regions identified could sometimes contain hundreds of genes. Here we combine high-resolution CGH analysis of 598 human cancer cell lines with insertion sites isolated from 1,005 mouse tumors induced with the murine leukemia virus (MuLV). This cross-species oncogenomic analysis revealed candidate tumor suppressor genes and oncogenes mutated in both human and mouse tumors, making them strong candidates for novel cancer genes. A significant number of these genes contained binding sites for the stem cell transcription factors Oct4 and Nanog. Notably, mice carrying tumors with insertions in or near stem cell module genes, which are thought to participate in cell self-renewal, died significantly faster than mice without these insertions. A comparison of the profile we identified to that induced with the Sleeping Beauty (SB) transposon system revealed significant differences in the profile of recurrently mutated genes. Collectively, this work provides a rich catalogue of new candidate cancer genes for functional analysis.

Original languageEnglish (US)
Pages (from-to)883-895
Number of pages13
JournalCancer Research
Issue number3
StatePublished - Feb 1 2010


Dive into the research topics of 'Novel candidate cancer genes identified by a large-scale cross-species comparative oncogenomics approach'. Together they form a unique fingerprint.

Cite this